CTC
NPTN

Central Trust Company’s NEOPHOTONICS CORP NPTN Stock Holding History

Central Trust Company’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-175
Closed -$2K – 1363
2021
Q3 		$2K Hold
175
– – ﹤0.01% 1219
2021
Q2 		$2K Hold
175
– – ﹤0.01% 1172
2021
Q1 		$2K Buy
+175
New +$1.98K ﹤0.01% 1093

Other funds holding NPTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Central Trust Company's NPTN Position: Q4 2021 in Review

Central Trust Company sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 175 shares — an estimated $2K sold.

Central Trust Company first reported a position in NPTN in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • Central Trust Company reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • Central Trust Company sold 175 NEOPHOTONICS CORP shares in Q4 2021, an estimated $2K.
  • Central Trust Company first reported a position in NEOPHOTONICS CORP in Q1 2021 and held it in 3 quarters.
  • Central Trust Company's NEOPHOTONICS CORP position peaked at $2K in Q3 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Central Trust Company's 13F filing for Q4 2021, filed 8 Feb 2022.